Review
Published on 02 Oct 2024
Single-cell profiling of cellular changes in the somatic peripheral nerves following nerve injury
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1448253
- 783 views
Type at least 3 characters
2,285 articles
Articles
Original Research
Published on 02 Oct 2024
Exploring novel natural compound-based therapies for Duchenne muscular dystrophy management: insights from network pharmacology, QSAR modeling, molecular dynamics, and free energy calculations
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1395014
- 1,065 views
Brief Research Report
Published on 02 Oct 2024
Synergistic effects of peripheral GABA and GABA-transaminase inhibitory drugs on food intake control and weight loss in high-fat diet-induced obese mice
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1487585
- 2,060 views
Original Research
Published on 01 Oct 2024
Hemoglobin α-derived peptides VD-hemopressin (α) and RVD-hemopressin (α) are involved in electroacupuncture inhibition of chronic pain
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1439448
- 775 views
Correction
Published on 30 Sep 2024
Corrigendum: Long-term efficacy and reduced side-effects of buprenorphine in patients with moderate and severe chronic pain
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1491886
- 430 views
Correction
Published on 27 Sep 2024
Corrigendum: Activation of EphrinB2/EphB2 signaling in the spine cord alters glia-neuron interactions in mice with visceral hyperalgesia following maternal separation
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1491784
- 404 views
Original Research
Published on 27 Sep 2024
Unraveling the pathogenic mechanism of a novel filamin a frameshift variant in periventricular nodular heterotopia
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1429177
- 522 views
Original Research
Published on 26 Sep 2024
Sex differences in nicotine intake and relapse behavior in nicotine-dependent adult wistar rats
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1415219
- 742 views
Original Research
Published on 26 Sep 2024
Deletion of arrestin-3 does not reduce drug-seeking behavior in a longitudinal paradigm of oral morphine self-administration
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1438037
- 519 views
- 1 citation
Review
Published on 26 Sep 2024
Exploring Copper’s role in stroke: progress and treatment approaches
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1409317
- 1,096 views
Original Research
Published on 25 Sep 2024
Eucalyptus essential oil exerted a sedative-hypnotic effect by influencing brain neurotransmitters and gut microbes via the gut microbiota-brain axis
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1464654
- 1,102 views
Original Research
Published on 24 Sep 2024
Lithocarpus polystachyus Rehd. ameliorates cerebral ischemia/reperfusion injury through inhibiting PI3K/AKT/NF-κB pathway and regulating NLRP3-mediated pyroptosis
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1365642
- 872 views
Original Research
Published on 23 Sep 2024
Adverse event signal mining and severe adverse event influencing factor analysis of Lumateperone based on FAERS database
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1472648
- 1,245 views
Original Research
Published on 23 Sep 2024
FGF21 inhibits ferroptosis caused by mitochondrial damage to promote the repair of peripheral nerve injury
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1358646
- 1,456 views
Original Research
Published on 20 Sep 2024
Transdermal buprenorphine patch as an adjunct to multimodal analgesia after total joint arthroplasty: a retrospective cohort study
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1412099
- 857 views
Original Research
Published on 19 Sep 2024
Long-term effects of siponimod on cardiovascular and autonomic nervous system in secondary progressive multiple sclerosis
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1431380
- 760 views